Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Sep 12, 2017

Cytomegalovirus (CMV) is more common than the Zika virus, yet few people know about the irreversible birth defects congenital CMV infection can cause. Jeff Baxter, CEO of VBI Vaccines, talks about the risks CMV poses to pregnant women and their unborn babies. Currently, there is no way to prevent contracting CMV during pregnancy and the irreversible birth defects that can result. Thankfully, VBI Vaccines is currently developing a vaccine to prevent CMV. If successful, this could be given to all adolescent-aged young women as a preventive measure.

@VBIVaccines

VBIVaccines.com

#CMV   #congenitalCMV   #CMVawareness

#vaccine   #CMVinfection   #stopCMV

VB